Skip to content

GMAB

Genmab A/S

NASDAQ · Healthcare · Biotechnology · DK

$57.76
+2.25%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
37.11x
P/E 2026E
49.34x
P/E 2027E
33.69x
P/E 2028E
21.87x
P/S forward
6.92x

Trailing multiples

Trailing twelve months

P/E TTM
45.23x
PEG TTM
2.08x
Price / book
5.96x
Price / sales
8.60x
Price / cash flow
39.89x

Enterprise value

Enterprise value
$39.3B
EV / sales
9.51x
EV / EBITDA
32.22x
EV / EBIT
29.45x
Market cap
$35.5B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026